Recently, it has been observed in a cohort of 56 HD patients a decrease in the levels of total Htt levels (using EM48 and CH00146 antibodies) and an increase in the levels of the N-terminal fragment without alteration in Htt mRNA levels. This evidence concerns the gene HTT and Huntington disease.